CAS 874902-19-9
:5-([1,1′-Biphenyl]-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide
Description:
5-([1,1′-Biphenyl]-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide, with the CAS number 874902-19-9, is a chemical compound characterized by its tetrazole ring, which is a five-membered heterocyclic structure containing four nitrogen atoms and one carbon atom. This compound features a biphenyl moiety, contributing to its aromatic characteristics and potentially influencing its solubility and reactivity. The presence of the dimethylamino group enhances its basicity and may affect its interaction with biological targets. The carboxamide functional group suggests potential for hydrogen bonding, which can play a significant role in its biological activity and solubility in polar solvents. Overall, this compound may exhibit interesting pharmacological properties, making it a subject of interest in medicinal chemistry and drug development. Its specific characteristics, such as melting point, solubility, and reactivity, would require empirical data for precise evaluation.
Formula:C17H17N5O
InChI:InChI=1S/C17H17N5O/c1-21(2)17(23)22-16(18-19-20-22)12-13-8-10-15(11-9-13)14-6-4-3-5-7-14/h3-11H,12H2,1-2H3
InChI key:InChIKey=GZNIYOXWFCDBBJ-UHFFFAOYSA-N
SMILES:C(C=1N(C(N(C)C)=O)N=NN1)C2=CC=C(C=C2)C3=CC=CC=C3
Synonyms:- 1H-Tetrazole-1-carboxamide, 5-([1,1′-biphenyl]-4-ylmethyl)-N,N-dimethyl-
- 5-([1,1′-Biphenyl]-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide
- LY 2183240
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
LY2183240
CAS:<p>LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM).</p>Formula:C17H17N5OPurity:99.26%Color and Shape:SolidMolecular weight:307.35LY-2183240
CAS:Controlled Product<p>LY-2183240 is a potent, selective, and orally bioavailable inhibitor of the enzyme fatty acid amide hydrolase. This molecule has been shown to reduce inflammation by inhibiting the production of proinflammatory cytokines in animal models. LY-2183240 also acts as an agonist at the CB2 receptor and inhibits skin cancer tumor growth. It also displays an efficacy profile that is similar to other pharmacological agents used to treat inflammatory bowel disease and idiopathic urticaria.</p>Purity:Min. 95%LY2183240
CAS:Controlled Product<p>Applications LY2183240 is a potent inhibitor of FAAH activity, and the uptake and enzymatic hydrolysis of anandamide. Synthetic Cannabinoids<br></p>Formula:C17H17N5OColor and Shape:NeatMolecular weight:307.35




